Skip to main content

Advertisement

Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models

BMC Cancer volume 16, Article number: 8 (2016) Cite this article

Article metrics

The original article was published in BMC Cancer 2015 15:941

Unfortunately, the original version of this article [1] contained a mistake. The word ‘survivin’ in the title was incorrectly included as ‘surviving’. The title has been corrected above and in the original article.

Reference

  1. 1.

    Gravina G, Mancini A, Sanita P, Vitale F, Marampon F, Ventura L. KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models. BMC Cancer. 2015;15:941.

Download references

Author information

Affiliations

  1. Department of Biotechnological and Applied Clinical Sciences, Laboratory of Radiobiology, University of L’Aquila, L’Aquila, Italy

    • Giovanni Luca Gravina
    • , Andrea Mancini
    • , Patrizia Sanita
    • , Flora Vitale
    • , Francesco Marampon
    •  & Claudio Festuccia

  2. Pathology Division, San, Salvatore Hospital, L’Aquila, Italy

    • Luca Ventura

  3. Karyopharm Therapeutics, Newton, MA, USA

    • Yosef Landesman
    • , Dilara McCauley
    • , Michael Kauffman
    •  & Sharon Shacham

Authors

  1. Search for Giovanni Luca Gravina in:

  2. Search for Andrea Mancini in:

  3. Search for Patrizia Sanita in:

  4. Search for Flora Vitale in:

  5. Search for Francesco Marampon in:

  6. Search for Luca Ventura in:

  7. Search for Yosef Landesman in:

  8. Search for Dilara McCauley in:

  9. Search for Michael Kauffman in:

  10. Search for Sharon Shacham in:

  11. Search for Claudio Festuccia in:

Corresponding author

Correspondence to Claudio Festuccia.

Additional information

The online version of the original article can be found under doi:10.1186/s12885-015-1936-z.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gravina, G.L., Mancini, A., Sanita, P. et al. Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models. BMC Cancer 16, 8 (2016) doi:10.1186/s12885-015-2046-7

Download citation

BMC Cancer

ISSN: 1471-2407

Contact us